Cargando…

Safety Profile and Neurocognitive Function Following Acute 4-Fluoroamphetamine (4-FA) Administration in Humans

Availability of novel psychoactive substances (NPS) exponentially increased over the last years. Risk evaluations of NPS are hampered by the lack of pharmacological studies in humans on health parameters. The aim of the present study was to evaluate safety and neurocognitive function of healthy volu...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Sousa Fernandes Perna, Elizabeth B., Theunissen, Eef L., Dolder, Patrick C., Mason, Natasha L., Hutten, Nadia R. P. W., Toennes, Stefan W., Kuypers, Kim P. C., Ramaekers, Johannes G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052735/ https://www.ncbi.nlm.nih.gov/pubmed/30050434 http://dx.doi.org/10.3389/fphar.2018.00713

Ejemplares similares

Drug liking and wanting, not impulsive action or reflection is increased by 4-fluoroamphetamine
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Neurocognition and Subjective Experience Following Acute Doses of the Synthetic Cannabinoid JWH-018: Responders Versus Nonresponders
por: Theunissen, Eef L., et al.
Publicado: (2019)

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
por: Ramaekers, Johannes G, et al.
Publicado: (2020)

4‐Fluoroamphetamine (4‐FA) intoxication results in exaggerated blood pressure effects compared to MDMA and amphetamine: A retrospective analysis
por: Gresnigt, Femke M. J., et al.
Publicado: (2022)

A Comparison of Acute Neurocognitive and Psychotomimetic Effects of a Synthetic Cannabinoid and Natural Cannabis at Psychotropic Dose Equivalence
por: Theunissen, Eef Lien, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Psychotomimetic symptoms after a moderate dose of a synthetic cannabinoid (JWH-018): implications for psychosis
por: Theunissen, Eef L., et al.
Publicado: (2021)

Subjective aggression during alcohol and cannabis intoxication before and after aggression exposure
por: De Sousa Fernandes Perna, E. B., et al.
Publicado: (2016)

A single dose of cocaine enhances prospective memory performance
por: Hutten, Nadia RPW, et al.
Publicado: (2018)

Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users
por: Ramaekers, Johannes G., et al.
Publicado: (2010)

Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2020)

Reduced responsiveness of the reward system is associated with tolerance to cannabis impairment in chronic users
por: Mason, Natasha L., et al.
Publicado: (2019)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective
por: Kuypers, Kim P. C., et al.
Publicado: (2016)

A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats
por: Uthaug, M. V., et al.
Publicado: (2021)

Cannabis Use and Neuroadaptation: A Call for Δ(9)-Tetrahydrocannabinol Challenge Studies
por: Ramaekers, Johannes G., et al.
Publicado: (2022)

Functional brain connectomes reflect acute and chronic cannabis use
por: Ramaekers, J. G., et al.
Publicado: (2022)

Erratum: Cannabis and tolerance: acute drug impairment as a function of cannabis use history
por: Ramaekers, J. G., et al.
Publicado: (2016)

Cannabis and tolerance: acute drug impairment as a function of cannabis use history
por: Ramaekers, J. G., et al.
Publicado: (2016)

Neurophysiological functioning of occasional and heavy cannabis users during THC intoxication
por: Theunissen, Eef L., et al.
Publicado: (2011)

Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter
por: Kuypers, K. P. C., et al.
Publicado: (2018)

Persisting Effects of Ayahuasca on Empathy, Creative Thinking, Decentering, Personality, and Well-Being
por: Kiraga, Maggie K., et al.
Publicado: (2021)

Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT(2) and 5-HT(1) Receptors
por: van Wel, Janelle H. P., et al.
Publicado: (2012)

Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
por: Mason, N. L., et al.
Publicado: (2020)

A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid
por: Bosker, W. M., et al.
Publicado: (2012)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
por: van der Pas, R.S.D., et al.
Publicado: (2020)

Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes
por: Ramaekers, J. G., et al.
Publicado: (2015)

Mephedrone and Alcohol Interactions in Humans
por: Papaseit, Esther, et al.
Publicado: (2020)

A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
por: Prevete, Elisabeth, et al.
Publicado: (2021)

Clinical Implications of Kratom (Mitragyna speciosa) Use: a Literature Review
por: Prevete, Elisabeth, et al.
Publicado: (2023)

Multifaceted empathy of healthy volunteers after single doses of MDMA: A pooled sample of placebo-controlled studies
por: Kuypers, Kim PC, et al.
Publicado: (2017)

Spontaneous and deliberate creative cognition during and after psilocybin exposure
por: Mason, N. L., et al.
Publicado: (2021)

Sub-acute and long-term effects of ayahuasca on affect and cognitive thinking style and their association with ego dissolution
por: Uthaug, M. V., et al.
Publicado: (2018)

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
por: Reckweg, Johannes, et al.
Publicado: (2021)

MDMA (ecstasy) effects on actual driving performance before and after sleep deprivation, as function of dose and concentration in blood and oral fluid
por: Bosker, Wendy M., et al.
Publicado: (2011)

Psychomotor Function in Chronic Daily Cannabis Smokers during Sustained Abstinence
por: Bosker, Wendy M., et al.
Publicado: (2013)

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
por: Reckweg, Johannes T., et al.
Publicado: (2023)

Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
por: van Oorsouw, Kim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k56p975fvsrljji0nibgiqki4u